The Future Commercial Winner for bonyf

bonyf NV / Key word(s): Market Launch/Development of Sales Periocream: The Future Commercial Winner for bonyf 11-Aug-2025 / 15:16 CET/CEST Periocream: The Future Commercial Winner for bonyf

    

periocream-03

Knokke-Heist (Belgium), 11 August 2025, 6:00 a.m.; bonyf NV (Ticker: MLBON), a leader in dental consumer goods, professional dental consumables and dermatological solutions, is preparing to launch Periocream, a groundbreaking dental treatment designed exclusively for dental professionals. At bonyf, we expect our Notified Body to release the final report shortly, confirming the product’s readiness for market. This unique product, protected by a European patent and with a U.S. patent pending, is poised to transform the management of dental procedures.

The Periocream 2025 Project, involving 30 patients across multiple clinical centers, demonstrated clinically significant improvements in healing and patient-reported comfort. The unique NitrAdine-based oxidative mechanism in Periocream effectively disrupts biofilm formation, supporting rapid mucosal recovery and superior post-treatment outcomes.

bonyf is currently finalizing the regulatory process to obtain Class IIa Medical Device registration covering the entire European market. Simultaneously, the company will submit Periocream to the U.S. Food and Drug Administration (FDA), with approval expected within approximately five months.

Interest in Periocream is already strong, with Dental Depots distributors from five European countries expressing their intention to partner with bonyf for the product’s rollout. In addition, bonyf’s U.S. partner will act as the exclusive importer for the vast U.S. market, while discussions are underway with a major Japanese distributor to cover Japan.